921.66MMarket Cap16.88P/E (TTM)
6.300High5.650Low1.59MVolume6.100Open6.430Pre Close9.62MTurnover1.36%Turnover Ratio16.88P/E (Static)147.58MShares9.27052wk High6.46P/B729.60MFloat Cap3.79052wk Low--Dividend TTM116.83MShs Float18.250Historical High--Div YieldTTM10.11%Amplitude0.309Historical Low6.057Avg Price1Lot Size
MiMedx Stock Forum
Investment Firm Raises Price Target For Major Biotech Company
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions.$MiMedx(MDXG.US)$
...
ColumnsToday's Pre-Market Stock Movers: ORCL, RENT, U, AKRO and More
In reaction to earnings/guidance:
• $Planet Labs PBC(PL.US)$ +11.3%,$Core & Main(CNM.US)$ +6.1%,$Regal Rexnord(RRX.US)$ +2% (reaffirms outlook),$Oracle(ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics(AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos(AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals(CPRX.US)$ +7.7...
No comment yet